Ross Daniel W, Hasan Zubair
Division of Kidney Diseases and Hypertension, Donald and Barbara Zucker School of Medicine at Hofstra-Northwell.
Division of Pulmonary, Critical Care, and Sleep Medicine, Donald and Barbara Zucker School of Medicine at Hofstra-Northwell.
POCUS J. 2022 Feb 1;7(Kidney):59-64. doi: 10.24908/pocus.v7iKidney.15344. eCollection 2022.
The severe acute respiratory virus covariate-2 (SARS CoV-2) that causes Corona Virus Disease 2019 (COVID-19) has affected more than 194 million people worldwide and has attributed to or caused more than 4 million deaths. Acute kidney injury (AKI) is a common complication of COVID-19. Point of care ultrasonography (POCUS) can be a useful tool for the nephrologist. POCUS can be used to elucidate the cause of kidney disease and then also help to manage volume status. Here, we review pearls and pitfalls of using POCUS to manage COVID-19 associated AKI with special attention to kidney, lung, and cardiac ultrasound.
导致2019冠状病毒病（COVID-19）的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）已在全球感染了超过1.94亿人，并导致或造成了超过400万人死亡。急性肾损伤（AKI）是COVID-19的常见并发症。床旁超声检查（POCUS）对肾病学家来说可能是一种有用的工具。POCUS可用于阐明肾脏疾病的病因，进而有助于管理容量状态。在此，我们回顾使用POCUS管理COVID-19相关AKI的要点和陷阱，特别关注肾脏、肺部和心脏超声。
